 It has been shown that an increase cfDNA in the plasma of ICU patients is an indicator of the onset of sepsis.Due to the severity of sepsis in ICU patients, further testing in order to determine the scope of cfDNA efficacy as a biomarker for septic risk is likely.Patients showing signs of myocardial infarction have been shown to have elevated cfDNA levels.